§ 212.20. What activities must I perform to ensure drug quality?
209 words·~1 min read·
/us/cfr/t21/s§ 212.20·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)Production operations. You must oversee production operations to ensure that each PET drug meets the requirements of the act as to safety and has the identity and strength, and meets the quality and purity characteristics, that it is supposed to have.
(b)Materials. You must examine and approve or reject components, containers, closures, in-process materials, packaging materials, labeling, and finished dosage forms to ensure compliance with procedures and specifications affecting the identity, strength, quality, or purity of a PET drug.
(c)Specifications and processes. You must approve or reject, before implementation, any initial specifications, methods, processes, or procedures, and any proposed changes to existing specifications, methods, processes, or procedures, to ensure that they maintain the identity, strength, quality, and purity of a PET drug. You must demonstrate that any change does not adversely affect the identity, strength, quality, or purity of any PET drug.
(d)Production records. You must review production records to determine whether errors have occurred. If errors have occurred, or a production batch or any component of the batch fails to meet any of its specifications, you must determine the need for an investigation, conduct investigations when necessary, and take appropriate corrective actions.
(e)Quality assurance. You must establish and follow written quality assurance procedures.
Connections5 cite this
Cited by 5 sections
Citation graph
cites case law
§ 212.20
What activities must I perform to ensure drug quality?
Fed. Reg.×5
Cites 0Cited by 5 across 1 source